Leukemia Posts on Medivizor
Navigation Menu

Leukemia Posts on Medivizor

CAR-T cell therapy and infection risk

Posted by on Dec 16, 2017 in Leukemia | 0 comments

In a nutshell This study examined infection risk in leukemia and lymphoma patients treated with CAR-T cell therapy, a new type of immunotherapy. Researchers reported that infection rates were comparable to other salvage therapies.  Some background Chimeric antigen receptor (CAR) T-cell therapy helps the immune system to fight cancer cells. In...

Read More

CAR-T cell therapy and infection risk

Posted by on Dec 16, 2017 in Leukemia | 0 comments

In a nutshell This study examined infection risk in leukemia and lymphoma patients treated with CAR-T cell therapy, a new type of immunotherapy. Researchers reported that infection rates were comparable to other salvage therapies.  Some background Chimeric antigen receptor (CAR) T-cell therapy helps the immune system to fight cancer cells. In...

Read More

A bone marrow biopsy at CLL diagnosis can help determine the need for treatment

Posted by on Dec 16, 2017 in Leukemia | 0 comments

In a nutshell This study examined the value of carrying out a bone marrow biopsy before beginning treatment for chronic lymphocytic leukemia (CLL). Researchers reported that a bone marrow biopsy at the time of diagnosis can help determine the need for treatment in CLL patients. Some background CLL is cancer of the blood and bone marrow. It is one...

Read More

PTSD and Cancer

PTSD and Cancer

Posted by on Dec 11, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 0 comments

“I think all too often we underestimate the impact of a cancer diagnosis on the mental health and well-being of the individual, thus it goes unaddressed.” ~Stephanie Zimmerman, MSN Receiving a diagnosis of cancer can bring on feelings of worry, fear, dread, anger, uncertainty and loss.  Research indicates that, for some people, these symptoms of...

Read More

Comparing transplant options for patients with acute myeloid leukemia and acute lymphoblastic leukemia

Posted by on Dec 9, 2017 in Leukemia | 0 comments

In a nutshell This study aimed to compare unrelated donor umbilical cord blood transplant and unrelated hematopoietic stem cell transplant in adult and pediatric patients with acute myeloid leukemia and acute lymphoblastic leukemia. This study concluded that unrelated donor umbilical cord blood transplants could be used more often as a treatment...

Read More

A review of venetoclax for previously treated CLL

Posted by on Dec 2, 2017 in Leukemia | 0 comments

In a nutshell This study reviewed evidence on venetoclax (Venclexta) for previously treated chronic lymphocytic leukemia (CLL). Some background Targeted therapy is the standard treatment of CLL. This includes the BCL2 inhibitor therapy venetoclax. BCL2 inhibitor therapy blocks a protein called BCL2 involved in leukemia cell growth. Venetoclax has...

Read More

A review of tyrosine kinase inhibitors for CML

Posted by on Dec 2, 2017 in Leukemia | 0 comments

In a nutshell This study reviewed evidence of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia (CML). Some background CML is a disease in which the bone marrow makes too many mature and immature white blood cells. Most patients are diagnosed in the chronic (early) phase. Over recent years, targeted therapy with tyrosine...

Read More

Examining predictors of treatment response to dasatinib

Posted by on Dec 1, 2017 in Leukemia | 0 comments

In a nutshell This study examined treatment outcomes with dasatinib (Sprycel) for chronic myeloid leukemia (CML). Researchers reported a fast and strong treatment response to first-line dasatinib, particularly in older patients. The levels of a genetic mutation known as BCR-ABL1 at 3 months was found to be a predictor of treatment response. Some...

Read More